VC-backed SQZ Biotech goes public

Watertown, Massachusetts-based SQZ Biotechnologies Company, a cell therapy company, has debuted its IPO after pricing its over 4.4 million shares at $16 per share.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this